Use of Lytic Bacteriophage for Control of Experimental Escherichia Coli Septicemia and Meningitis in Chickens and Calves

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1998 May 30

PMID 9605979

Citations 85

Authors

P Barrow

M Lovell

A Berchieri Jr

Affiliations

Soon will be listed here.

Abstract

A lytic bacteriophage, which was previously isolated from sewage and which attaches to the K1 capsular antigen, has been used to prevent septicemia and a meningitis-like infection in chickens caused by a K1+ bacteremic strain of Escherichia coli. Protection was obtained even when administration of the phage was delayed until signs of disease appeared. The phage was able to multiply in the blood. In newly borne colostrum-deprived calves given the E. coli orally, intramuscular inoculation of phage delayed appearance of the bacterium in the blood and lengthened life span. With some provisos there is considerable potential for this approach to bacterial-disease therapy.

Citing Articles

Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.

Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S Clin Microbiol Rev. 2024; 37(3):e0004424.

PMID: 39072666 PMC: 11391690. DOI: 10.1128/cmr.00044-24.

Bacteriophage Therapy in Companion and Farm Animals.

Bianchessi L, De Bernardi G, Vigorelli M, DallAra P, Turin L Antibiotics (Basel). 2024; 13(4).

PMID: 38666970 PMC: 11047634. DOI: 10.3390/antibiotics13040294.

Phage-Based Biosanitation Strategies for Minimizing Persistent and Bacteria in Poultry.

Jorda J, Lorenzo-Rebenaque L, Montoro-Dasi L, Marco-Fuertes A, Vega S, Marin C Animals (Basel). 2023; 13(24).

PMID: 38136863 PMC: 10740442. DOI: 10.3390/ani13243826.

Phage Interactions with the Nervous System in Health and Disease.

Jedrusiak A, Fortuna W, Majewska J, Gorski A, Jonczyk-Matysiak E Cells. 2023; 12(13).

PMID: 37443756 PMC: 10341288. DOI: 10.3390/cells12131720.

Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis.

Alexyuk P, Bogoyavlenskiy A, Alexyuk M, Akanova K, Moldakhanov Y, Berezin V Microorganisms. 2023; 11(6).

PMID: 37375026 PMC: 10302289. DOI: 10.3390/microorganisms11061524.

References

Smith H, Huggins M . Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol. 1982; 128(2):307-18. DOI: 10.1099/00221287-128-2-307. View

Smith H . Transmissible pathogenic characteristics of invasive strains of Escherichia coli. J Am Vet Med Assoc. 1978; 173(5 Pt 2):601-7. View

Smith H, Huggins M . The influence of plasmid-determined and other characteristics of enteropathogenic Escherichia coli on their ability to proliferate in the alimentary tracts of piglets, calves and lambs. J Med Microbiol. 1978; 11(4):471-92. DOI: 10.1099/00222615-11-4-471. View

Smith H, Huggins M . Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract. J Gen Microbiol. 1976; 92(2):335-50. DOI: 10.1099/00221287-92-2-335. View

Barrow P . Bacteriophages mediating somatic antigenic conversion in Salmonella cholerae-suis: their isolation from sewage and other Salmonella serotypes possessing the somatic 6 antigen. J Gen Microbiol. 1986; 132(3):835-7. DOI: 10.1099/00221287-132-3-835. View

DUBOS R, Straus J, Pierce C . THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE. J Exp Med. 2009; 78(3):161-8. PMC: 2135327. DOI: 10.1084/jem.78.3.161. View

Smith H, Huggins M . Treatment of experimental Escherichia coli infection in mice with colicine V. J Med Microbiol. 1977; 10(4):479-82. DOI: 10.1099/00222615-10-4-479. View

Smith H, Huggins M . Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice. J Hyg (Lond). 1985; 95(2):363-74. PMC: 2129539. DOI: 10.1017/s0022172400062781. View

Smith H, Huggins M . Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol. 1983; 129(8):2659-75. DOI: 10.1099/00221287-129-8-2659. View

10.

Smith H, Huggins M . The effect of plasmid-determined and other characteristics on the survival of Escherichia coli in the alimentary tract of two human beings. J Gen Microbiol. 1978; 109(2):375-9. DOI: 10.1099/00221287-109-2-375. View

11.

Berchieri Jr A, Lovell M, Barrow P . The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res Microbiol. 1991; 142(5):541-9. DOI: 10.1016/0923-2508(91)90187-f. View

12.

Soothill J . Treatment of experimental infections of mice with bacteriophages. J Med Microbiol. 1992; 37(4):258-61. DOI: 10.1099/00222615-37-4-258. View

13.

Keller R, ENGLEY Jr F . Fate of bacteriophage particles introduced into mice by various routes. Proc Soc Exp Biol Med. 1958; 98(3):577-80. DOI: 10.3181/00379727-98-24112. View

14.

Smith H, Huggins M, Shaw K . The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol. 1987; 133(5):1111-26. DOI: 10.1099/00221287-133-5-1111. View

15.

Sarff L, McCRACKEN G, Schiffer M, Glode M, Robbins J, ORSKOV I . Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet. 1975; 1(7916):1099-104. DOI: 10.1016/s0140-6736(75)92496-4. View

16.

Smith H, Cook J, Parsell Z . The experimental infection of chickens with mixtures of infectious bronchitis virus and Escherichia coli. J Gen Virol. 1985; 66 ( Pt 4):777-86. DOI: 10.1099/0022-1317-66-4-777. View

17.

Barrow P, Soothill J . Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 1997; 5(7):268-71. DOI: 10.1016/S0966-842X(97)01054-8. View

18.

Topley W, Wilson J . Further Observations on the Rôle of the Twort-d'Herelle Phenomenon in the Epidemic Spread of Mouse-typhoid. J Hyg (Lond). 2010; 24(3-4):295-300. PMC: 2167654. DOI: 10.1017/s0022172400008755. View

19.

SLOPEK S, Weber-Dabrowska B, Dabrowski M, KUCHAREWICZ-KRUKOWSKA A . Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp (Warsz). 1987; 35(5):569-83. View

20.

Merril C, Biswas B, Carlton R, Jensen N, Creed G, Zullo S . Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A. 1996; 93(8):3188-92. PMC: 39580. DOI: 10.1073/pnas.93.8.3188. View